Marimed (MRMD) Income from Non-Controlling Interests (2016 - 2026)

Marimed's (MRMD) quarterly Income from Non-Controlling Interests came in at $18000.0 in Q1 2026, down 43.75% year-on-year from $32000.0 in Q1 2025, and up 280.0% on a QoQ basis from -$10000.0 in Q4 2025.

Marimed (MRMD) Income from Non-Controlling Interests (2016 - 2026) Analysis & Trends

Marimed (MRMD) has 11 years of Income from Non-Controlling Interests data on file, last reported at $18000.0 in Q1 2026.

  • On a quarterly basis, Income from Non-Controlling Interests fell 43.75% year-over-year to $18000.0 in Q1 2026; TTM through Mar 2026 was $14000.0, a 77.78% decrease from a year earlier, with the FY2025 full-year figure at $28000.0, down 24.32% from the prior year.
  • Income from Non-Controlling Interests for Q1 2026 stood at $18000.0, up from -$10000.0 in the prior quarter.
  • Over the last five years, Income from Non-Controlling Interests for MRMD reached as high as $73000.0 in Q2 2022 and fell as low as -$19000.0 in Q1 2023.
  • Historically, Income from Non-Controlling Interests has averaged $14882.4 across 5 years, with a median of $12000.0 in 2024.
  • Across the five-year window, Income from Non-Controlling Interests jumped 650.0% in 2023 and tumbled 433.33% in 2025, its largest moves.
  • Year by year, Income from Non-Controlling Interests stood at $4000.0 in 2022, then soared by 650.0% to $30000.0 in 2023, then sank by 90.0% to $3000.0 in 2024, then tumbled by 433.33% to -$10000.0 in 2025, then jumped by 280.0% to $18000.0 in 2026.
  • Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were $18000.0 in Q1 2026, -$10000.0 in Q4 2025, and $7000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Haleon 88.58 Bn 86.72 Bn - -
2 Teva Pharmaceutical Industries 35.90 Bn 32.16 Bn 1.97 Bn -
3 Zoetis 32.33 Bn 30.39 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.49 Bn 23.43 Bn 4.39 Bn 395,346.10
5 United Therapeutics 23.14 Bn 20.99 Bn 648.10 Mn -
6 RedHill Biopharma 20.53 Bn 20.53 Bn - -
7 Viatris 20.29 Bn 18.49 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.93 Bn 16.62 Bn 800.70 Mn -12.70 Mn
9 Elanco Animal Health 12.63 Bn 12.21 Bn 785.00 Mn -
10 Marimed 23.85 Mn 14.02 Mn 15.28 Mn 18,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 18,000.00
Dec 31, 2025 -10,000.00
Sep 30, 2025 7,000.00
Jun 30, 2025 -1,000.00
Mar 31, 2025 32,000.00
Dec 31, 2024 3,000.00
Sep 30, 2024 16,000.00
Jun 30, 2024 12,000.00
Mar 31, 2024 6,000.00
Dec 31, 2023 30,000.00
Sep 30, 2023 -10,000.00
Jun 30, 2023 23,000.00
Mar 31, 2023 -19,000.00
Dec 31, 2022 4,000.00
Sep 30, 2022 16,000.00
Jun 30, 2022 73,000.00
Mar 31, 2022 53,000.00
Dec 31, 2021 110,000.00
Sep 30, 2021 103,000.00
Jun 30, 2021 96,000.00